Bankruptcy Blogs

My Bankruptcy Law Network colleague Craig Andresen

K-V Pharmaceutical Co . filed for Chapter 11 bankruptcy, a move it said was propelled by the U.S. Food and Drug Administration ‘s failure to enforce orphan drug exclusivity granted to K-V’s key premature-birth drug, Makena. Read the Dow Jones story here in Daily  Bankruptcy Review.

Receiving Wide Coverage ...

The Computer Is Killing Brokerage Firms: Trading firm Knight Capital suffered $440 million in losses after its new software system went crazy and swamped the stock market with errant trades. The Times reports Knight bumped up against a deadline and used the software, designed to take advantage of a new Wall Street trading venue, before it had to time to work out the glitches. Fortunately, the market handled the malfunction; it was...